117 related articles for article (PubMed ID: 1972051)
1. [Side-effects of neuroleptics].
Wolf MA; Villeneuve A
Encephale; 1990; 16(2):111-24. PubMed ID: 1972051
[TBL] [Abstract][Full Text] [Related]
2. [Drug side effects on the nervous system].
Ludin HP
Ther Umsch; 1993 Jan; 50(1):23-7. PubMed ID: 8104359
[TBL] [Abstract][Full Text] [Related]
3. [Current data on neurologic sequelae caused by neuroleptics].
Krebs MO
Encephale; 1995 Jun; 21 Spec No 3():49-52. PubMed ID: 7628342
[TBL] [Abstract][Full Text] [Related]
4. [Neuroleptic-induced movement disorders: historical perspectives].
Wolf MA; Yassa R; Llorca PM
Encephale; 1993; 19(6):657-61. PubMed ID: 12404786
[TBL] [Abstract][Full Text] [Related]
5. [New chemotherapy approaches to psychoses].
Olié JP; Baylé FJ
Encephale; 1997 Apr; 23 Spec No 2():2-9. PubMed ID: 9273302
[TBL] [Abstract][Full Text] [Related]
6. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
Khaldi S; Kornreich C; Choubani Z; Gourevitch R
Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
[TBL] [Abstract][Full Text] [Related]
7. Novel pharmacological approaches to the treatment of schizophrenia.
Fink-Jensen A
Dan Med Bull; 2000 Jun; 47(3):151-67. PubMed ID: 10913983
[TBL] [Abstract][Full Text] [Related]
8. Depot neuroleptics: side effects and safety.
Marder SR
J Clin Psychopharmacol; 1986 Feb; 6(1 Suppl):24S-29S. PubMed ID: 2870089
[TBL] [Abstract][Full Text] [Related]
9. Iron modulates neuroleptic-induced effects related to the dopaminergic system.
Ben-Shachar D; Livne E; Spanier I; Zuk R; Youdim MB
Isr J Med Sci; 1993 Sep; 29(9):587-92. PubMed ID: 7901181
[TBL] [Abstract][Full Text] [Related]
10. Neuroleptic-induced acute extrapyramidal syndromes and tardive dyskinesia.
Casey DE
Psychiatr Clin North Am; 1993 Sep; 16(3):589-610. PubMed ID: 8105453
[TBL] [Abstract][Full Text] [Related]
11. Quetiapine-induced neuroleptic malignant syndrome in dementia with Lewy bodies: a case report.
Kobayashi A; Kawanishi C; Matsumura T; Kato D; Furukawa R; Kishida I; Hirayasu Y
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1170-2. PubMed ID: 16682107
[TBL] [Abstract][Full Text] [Related]
12. [Neuroleptic malignant syndrome: a review of literature].
Crespo Facorro B; Carbonell Masia C
Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1995; 23(5):273-8. PubMed ID: 8553925
[TBL] [Abstract][Full Text] [Related]
13. [Neuroleptics in geriatrics. Pharmacological criteria for a responsible choice and a correct use].
van Wielink PS
Tijdschr Gerontol Geriatr; 1984 Apr; 15(2):73-80. PubMed ID: 6144201
[TBL] [Abstract][Full Text] [Related]
14. [Iatrogenic extrapyramidal disorders].
Ludin HP
Schweiz Med Wochenschr; 1990 Jun; 120(23):855-8. PubMed ID: 1972812
[TBL] [Abstract][Full Text] [Related]
15. Atypical neuroleptics in the treatment of early onset schizophrenia.
Masi G
Panminerva Med; 1997 Sep; 39(3):215-21. PubMed ID: 9360425
[TBL] [Abstract][Full Text] [Related]
16. [Extrapyramidal reactions and neuroleptic malignant syndrome].
Gómez EA
Acta Psiquiatr Psicol Am Lat; 1984 Dec; 30(4):281-6. PubMed ID: 6535382
[TBL] [Abstract][Full Text] [Related]
17. Movement disorders associated with neuroleptic treatment.
Wirshing WC
J Clin Psychiatry; 2001; 62 Suppl 21():15-8. PubMed ID: 11584982
[TBL] [Abstract][Full Text] [Related]
18. [Neuroleptic malignant syndrome. Case reports].
Berardi D; Troia M; Veronesi L; Ferrari G
Minerva Psichiatr; 1994 Dec; 35(4):199-219. PubMed ID: 7861943
[TBL] [Abstract][Full Text] [Related]
19. Effect of piracetam on extrapyramidal side effects induced by neuroleptic drugs.
Kabes J; Sikora J; Pisvejc J; Hanzlicek L; Skondia V
Int Pharmacopsychiatry; 1982; 17(3):185-92. PubMed ID: 6128331
[TBL] [Abstract][Full Text] [Related]
20. Comparative neurochemical changes associated with chronic administration of typical and atypical neuroleptics: implications in tardive dyskinesia.
Bishnoi M; Kumar A; Chopra K; Kulkarni SK
Indian J Exp Biol; 2007 Feb; 45(2):175-9. PubMed ID: 17375557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
